South Korea’s newly formed Lotte Biologics bought Bristol Myers Squibb’s multibuilding biopharmaceutical production facility in Syracuse, New York, for $160 million, in the largest commercial real estate deal on record in the market this century.
South Korea’s newly formed Lotte Biologics bought Bristol Myers Squibb’s multibuilding biopharmaceutical production facility in Syracuse, New York, for $160 million, in the largest commercial real estate deal on record in the market this century.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In